Overexpression of metastasis associated in lung adenocarcinoma transcript 1 (MALAT1) is associated with poor prognosis in tamoxifen-treated ER+ breast cancer patients, and might be considered as a potential biomarker to predict endocrine treatment sensitivity25. The gene discussed is MALAT1; the disease is breast cancer.